Bone morphogenetic protein receptor type 1 complex (BMPR1 complex)

The Bone morphogenetic protein receptor type 1 (BMPR1) complex is a heteromeric signaling assembly of transmembrane serine/threonine kinases belonging to the transforming growth factor-beta (TGF-beta) superfamily. It typically consists of Type 1 receptors—such as BMPR1A (ALK3), BMPR1B (ALK6), or ACVR1 (ALK2)—which form functional complexes with Type 2 receptors (e.g., BMPR2) upon binding of bone morphogenetic protein (BMP) ligands. The Type 2 receptor constitutively phosphorylates the Type 1 receptor, which then activates the canonical SMAD1/5/8 signaling pathway to regulate genes essential for bone and cartilage development, cell fate determination, and tissue homeostasis. Dysregulation of this complex is a hallmark of several pathologies, most notably Fibrodysplasia ossificans progressiva (FOP), where gain-of-function mutations in ACVR1 lead to catastrophic heterotopic ossification. The complex is also a target in oncology and cardiovascular research, with therapeutic efforts focusing on small molecule kinase inhibitors designed to selectively block aberrant BMP signaling while minimizing off-target effects on related TGF-beta pathways. Note that while "BMP1" refers to a metalloprotease enzyme (procollagen C-proteinase), the term "BMP1 receptor" is frequently used in literature to refer to the Type 1 signaling receptors.

Other names

BMPR1BMPR-1ALK-2/3/6Bone morphogenetic protein receptor type IACVR1BMPR1ABMPR1BBone morphogenetic protein 1 receptor

Inhibition of the intracellular serine/threonine kinase domain of Type 1 BMP receptors, preventing the phosphorylation of SMAD1/5/8 effectors and subsequent gene transcription.